Cargando…
Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: Effect on eosinophil density and activation in relation to pharmacokinetics
BACKGROUND: We have previously demonstrated the clinical efficacy of montelukast in a randomized double-blind controlled cross-over trial in patients with dyspepsia in association with duodenal eosinophilia. The mechanism of this clinical response is unknown but could involve a decrease in eosinophi...
Autores principales: | Friesen, Craig A, Neilan, Nancy A, Schurman, Jennifer V, Taylor, Debra L, Kearns, Gregory L, Abdel-Rahman, Susan M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685805/ https://www.ncbi.nlm.nih.gov/pubmed/19432972 http://dx.doi.org/10.1186/1471-230X-9-32 |
Ejemplares similares
-
Intestinal permeability in children/adolescents with functional dyspepsia
por: Neilan, Nancy A, et al.
Publicado: (2014) -
The Gastric and Duodenal Eosinophilia in Functional Dyspepsia
por: Kim, Hyun Jin
Publicado: (2016) -
Prevalence of overlap syndromes and symptoms in pediatric functional dyspepsia
por: Friesen, Craig A., et al.
Publicado: (2016) -
Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study
por: Du, Lijun, et al.
Publicado: (2016) -
Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study
por: Du, Lijun, et al.
Publicado: (2017)